Infectious bronchitis in Brazil by Olofsson, Cecilia
 
 
 
Sveriges lantbruksuniversitet  
Swedish University of Agricultural Sciences  
Faculty of Veterinary Medicine and Animal Science 
Department of Biomedical Science and Veterinary Public 
Health 
Infectious Bronchitis in Brazil- a Minor Field Study 
in Bastos Municipality, São Paulo 
Caroline Olofsson 
 
 
 
Uppsala 
 
2012 
Degree Project within the Veterinary Medicine Program 
 
ISSN 1652-8697 
Degree Project 2012:32 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SLU 
Sveriges lantbruksuniversitet 
Swedish University of Agricultural Sciences 
 
Infectious Bronchitis in Brazil- a Minor Field Study 
in Bastos Municipality, São Paulo  
 
Caroline Olofsson 
 
 
Supervisor: Mikael Berg, Department of Biomedical Science and Veterinary Public Health, SLU   
Assistant Supervisors: Paulo E. Brandão, Department of Preventive Veterinary Medicine and Animal Health, 
University of São Paulo 
Siamak Zohari, Department of Biomedical Science and Veterinary Public Health, SLU   
Examiner: Tommy Linné, Department of Biomedical Science and Veterinary Public Health, SLU   
 
 
 
  
 
Degree Project within the Veterinary Medicine Program 
Faculty of Veterinary Medicine and Animal Science 
Department of Biomedical Science and Veterinary Public Health  
Course number: EX0234, Advanced Level, 30hp 
 
Keywords: IBV, Coronavirus, Poultry, Brazil, Genotypes, Biosecurity 
 
Online publication of this work: http://epsilon.slu.se 
ISSN 1652-8697 
Degree Project 2012:32 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONTENTS 
SUMMARY ............................................................................................................. 1 
SAMMANFATTNING ........................................................................................... 1 
INTRODUCTION ................................................................................................... 2 
Introduction .......................................................................................................... 2 
Incidence and distribution .................................................................................... 3 
Infectious bronchitis in Brazil .............................................................................. 3 
Aim ...................................................................................................................... 4 
LITERATURE STUDY .......................................................................................... 4 
Etiology ................................................................................................................ 4 
Morphology ......................................................................................................... 4 
Gene function and organization ........................................................................... 4 
Classification ....................................................................................................... 5 
Strain classification in IBV Diagnosis ............................................................. 6 
Pathogenicity ....................................................................................................... 7 
Transmission and incubation period .................................................................... 7 
Hosts .................................................................................................................... 8 
Clinical signs ........................................................................................................ 8 
Mortality and morbidity ....................................................................................... 9 
Gross lesions and histopathology ........................................................................ 9 
Immunity .............................................................................................................. 9 
Maternal antibodies ........................................................................................ 10 
Control of immunity ...................................................................................... 10 
Diagnosis ........................................................................................................... 10 
Methods for viral detection ............................................................................ 11 
Methods for antibody detection ..................................................................... 12 
Differential diagnosis ......................................................................................... 13 
Treatment ........................................................................................................... 13 
Biosecurity ......................................................................................................... 13 
Vaccination ........................................................................................................ 14 
Vaccination routines ...................................................................................... 14 
METHOD AND MATERIALS ............................................................................. 15 
Collection of samples ......................................................................................... 15 
Farms and flocks ............................................................................................ 15 
Organ samples ................................................................................................ 16 
Blood samples ................................................................................................ 16 
Additional information .................................................................................. 16 
Laboratory methods ........................................................................................... 16 
Background on laboratory methods used ....................................................... 16 
Execution at the lab ........................................................................................ 18 
RESULTS .............................................................................................................. 22 
Laboratory results .............................................................................................. 22 
3’ UTR Nested RT-PCR ................................................................................ 23 
Spike-gene Nested RT- PCR ......................................................................... 23 
Sequencing, Genome analysis and Phylogenetic analysis ............................. 23 
Genotype Specific Multiplex RT-PCR .......................................................... 24 
Serum antibody analysis with blocking ELISA ............................................. 25 
Results on Additional information and Biosecurity .......................................... 26 
Clinical history, clinical symptoms and gross pathological lesions .............. 26 
Biosecurity ..................................................................................................... 27 
DISCUSSION ........................................................................................................ 29 
IBV ..................................................................................................................... 29 
ELISA ................................................................................................................ 31 
Biosecurity ......................................................................................................... 31 
Limitations of the study ..................................................................................... 32 
Final conclusions ............................................................................................... 32 
ACKNOWLEDGMENTS ..................................................................................... 34 
REFERENCES ...................................................................................................... 35 
 1 
SUMMARY 
Infectious Bronchitis (IB) is a highly contagious viral respiratory and production 
depressant disease distributed world wide. The disease is caused by the Infectious 
Bronchitis Virus (IBV), a positive RNA strand Avian Coronavirus within the 
genus Gammacoronavirus. Due to a combination of high mutation rate and a 
tendency of recombination a constant emergence of new genotypes and serotypes 
is seen. In Brazil, a country with an extensive poultry production and major 
problems with disease control, the diversity of circulating strains are wide and 
outbreaks of clinical disease despite intensive use of vaccines are common. The 
aim of this study was to investigate the presence of IBV and to identify genotypes 
of isolated IBVs in a limited number of layer flocks in Bastos, São Paulo, as part 
of the screening for circulating genotypes in the country. As a minor part the 
Biosecurity measures (precautions) was observed. In addition, a literature study 
was performed on IB and IBV. Organ samples from four farms were collected as 
pools of trachea, lungs, kidneys, reproductive tract and enteric content and were 
analyzed using Reverse Transcriptase Polymerase Chain Reaction (RT-PCR). 
Over fifty percent of the samples were positive for IBV and three samples were 
identified as 4/91-genotype using Genotype-specific PCR. Due to problems with 
the RT-PCR that was targeting part of the S1-gene, the genotypes of the rest of the 
positive samples could not be determined using DNA sequencing. They were 
instead identified as not belonging to Massachusetts, D274 or 4/91 genotypes 
using Genotype-specific RT-PCR. Considering the results of previous studies in 
Brazil stating that a national Brazilian Variant dominates, the possibility that the 
unidentified genotypes belonged to the national genotype were considered high.  
Keywords: IBV, Coronavirus, Poultry, Brazil, Genotypes, Biosecurity 
 
SAMMANFATTNING 
Infektiös Bronkit är en mycket smittsam viral respiratorisk och 
produktionsnedsättande sjukdom som är spridd över hela världen. Sjukdomen 
orsakas av ett positivt RNA-virus tillhörande Aviära Coronavirus inom genus 
Gammacoronavirus, kallat Infektiöst Bronkit Virus (IBV). Virusets egenskaper 
såsom hög mutationsfrekvens i kombination med tendens till rekombination leder 
till konstant uppkomst av nya serotyper och genotyper. I Brasilien, ett land med 
både omfattande fjäderfäproduktion och stora problem med sjukdomskontroll, är 
variationen mellan cirkulerande stammar stor och utbrott av klinisk sjukdom trots 
utbredd användning av vaccin är vanligt. Syftet med den här studien var att 
undersöka förekomst av IBV och att identifiera genotyper av isolerade IBVs i ett 
begränsat antal värphönsflockar i Bastos, São Paulo, som del av den pågående 
screeningen med avseende på cirkulerande genotyper i landet. Som ett mindre 
delsyfte utfördes observationer med avseende på hur väl biosäkerheten var 
utvecklad. Vidare utfördes en litteraturstudie avseende IB och IBV. Organprover 
samlades in från fyra gårdar som pooler bestående av trachea, lungor, njurar, 
reproduktionsorgan och tarminnehåll och proverna analyserades med Reverse 
Transcriptase Polymerase Chain Reaction (RT-PCR). Mer än hälften av proverna 
var positiva för IBV och tre prover identifierades som genotyp 4/91 med Genotyp-
Specifik PCR. På grund av problem med den RT-PCR som var riktad mot delar av 
S1-genen kunde resterande positiva provers genotyp inte identifieras via DNA 
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sekvensering. Med Genotypspecifik PCR kunde de dock identifieras som icke 
tillhörande någon av genotyperna Massachusetts, D274 eller 4/91. Med hänsyn till 
resultat från tidigare studier där en nationell Brasiliansk Variant visats dominera, 
bedömdes sannolikheten att de oidentifierade proverna skulle tillhöra den 
nationella genotypen som stor.  
Nyckelord: IBV, Coronavirus, fjäderfä, Brasilien, Genotyp, Biosäkerhet 
 
INTRODUCTION 
Introduction 
Infectious bronchitis (IB) is a highly contagious viral respiratory and production 
suppressant disease that causes major financial losses and decrease in animal well 
fare in poultry flocks all over the world (Cavanagh, 2008; Engström et al, 2010).  
The disease was first described in North Dakota, USA, in the 1930s, as an acute 
and highly infectious respiratory disease in chicken (Cavanagh, 2008; Pattison et 
al, 2008). The etiology at this time was unknown. The causative agent, the Avian 
Coronavirus Infectious Bronchitis Virus (IBV), was discovered in 1936 by Beach 
and Schalm (Cavanagh, 2008). IB became very important due to the financial 
losses that outbreaks resulted in, the worldwide distribution and the various 
manifestations the disease exhibited. Apart from respiratory disease, poor weight 
gain in broilers, and prominent (often persistent) decreases in egg production and 
egg quality in layers, are results of IBV infection. Furthermore, kidney disease 
may develop. Complications with secondary bacterial infections are common and 
may result in an increase in mortality (Cavanagh, 2008). 
Many factors contribute to the problems of IB control. The highly contagious 
nature of the disease, resulting in rapid and thorough transmission within a flock, 
and the tendency of the virus to constant emerge into new serotypes and 
genotypes are true challenges for the poultry industry (Cavanagh, 2008; Engström 
et al, 2010). There is a constant need for development of new vaccines since the 
cross protection between serotypes has shown to be low (Cavanagh, 2007) and 
outbreaks in vaccinated flocks occur (Cavanagh, 2008).  
Virus neutralization (VN) and Hemagglutination inhibition (HI) test have 
traditionally been used to distinguish serotypes (Cavanagh, 2007). A lot of 
research has been aimed at the gene for the membrane bound glycoprotein called 
Spike, the S-gene, due to its importance in antigenic variation (Cavanagh, 2007). 
Nowadays nucleic acid analysis is thoroughly used when it comes to classification 
and molecular epidemiology studies, and the definition is then into genotypes 
instead of serotypes (Jones et al, 2009). Monoclonal Antibody analyses like 
ELISA are commonly used for prevalence screening for detection of anti-IBV 
antibodies (OIE Terrestrial Manual, 2008).  
IBV was long considered to be limited to infect chicken (Gallus gallus). However, 
results from recent research indicate that the host range is much wider and Avian 
Coronaviruses have now been isolated in both gallinaceous and non-gallinaceous 
species (Cavanagh, 2008).  
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Incidence and distribution 
Infectious bronchitis is distributed world wide (Cavanagh, 2008). The 
Massachusetts serotype is found globally and the presence of other genotypes 
varies. In the USA several types of major importance have been identified and in 
other parts of the world, dozens of others have been isolated (Cavanagh, 2008; De 
Wit et al, 2010).  In some areas in Asia, Africa, Australia and Latin America, 
regional variants have developed (Jones et al, 2009).  
The way of transmission between continents are often unknown and the role of 
wild migratory birds is not yet established (Jones et al, 2009; Jones, 2010). 
 
Infectious bronchitis in Brazil 
The major Brazilian poultry regions are located in the Southern, Southeastern, 
Northeastern and Central western parts of Brazil. The avian population density 
within these regions is very high and the flocks and farms are located in a close 
distance (Villarreal et al, 2010). Infection with IBV is a huge problem in all 
categories of poultry, i.e. broilers, breeders and layers (Brandão et al, 2009) and 
despite intensive use of vaccines, outbreaks with clinical disease are common 
(Villarreal et al, 2007a). The share of flocks being positive for IBV has been 
shown to be as high as 50-100 % (Brandão et al, 2009).  
An important factor contributing to the challenge for the poultry industry in Brazil 
to fight IBV infections is that only one type of  live attenuated vaccine is 
approved by the Brazilian Ministry of Agriculture,  Massachusetts – serotype 
vaccine. This presents a big concern since the genotypes of the IB virus in Brazil 
are highly divergent and the majority belongs to Non-Massachusetts types 
(Villarreal et al, 2010, Brandão, 2010).  A specific Brazilian genotype Variant 
closer related to the European serotype D274 than to the Massachusetts serotype 
is present (Villarreal et al, 2007a) and the cross-protection between this Variant 
and Mass serotypes is thought to be low- moderate (Villarreal et al, 2010).  
The significant variation in genotypes circulating among the Brazilian poultry was 
confirmed by a study performed by Villarreal et al in 2007-2008 (Villarreal et al, 
2010).  85 % (17/20) of the strains identified in IBV positive flocks belonged to 
Non-Massachusetts strains.  Three quarters belonged to the Brazilian genotype 
and within this genotype, three subclusters were outlined. Furthermore, two 
strains of the genotype 4/91 (also known as 793 B), not before detected in Brazil, 
were found (Villarreal et al, 2010). The authors suggested that this may be an 
indication of the emergence of this genotype into Latin America (Villarreal et al, 
2010), especially since a strain similar to this has been detected before in a non 
specified country in Latin America (Jones et al, 2009).  
Current research, not yet published, are being performed by the Coronavirus 
research group in Brazil regarding IBV infection in quails and the possibility of 
quails serving as a reservoir for IBV (Brandão, 2010). Results obtained so far 
indicates that this may be the case. This would require even further measurements 
for the poultry industry in Brazil since farms with both chicken and quails are not 
uncommon and usually quails are not vaccinated against IBV (Brandão, personal 
communication, 2011-11-03).  
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Aim 
The aim of this study was to: I) achieve further knowledge of the disease 
Infectious Bronchitis and the causative virus through a literature study; II) to 
study the presence of the IB virus in a number of flocks in Bastos, one of the 
major areas for layers in Brazil; and III) to identity the genotypes of the virus 
obtained as part of the continuously ongoing screening for strains circulating in 
the country. As a minor part, IV), the biosecurity measures were observed and 
blood samples for antibody analysis were collected.  
 
LITERATURE STUDY 
Etiology  
Infectious bronchitis virus (IBV) belongs to the family Coronaviridae in the order 
Nidovirales. The family Coronaviridae is divided into two subfamilies: 
Coronavirinae and Torovirinae (Cavanagh, 2008; Cavanagh, 2007; IVCT 
website). Virus within the Coronavirinae can infect a number of animals including 
humans, birds, cattle, pigs, dogs, cats and rodents (Pattison et al, 2008). 
Coronavirinae are divided into the genera Alphacoronavirus, Betacoronavirus and 
Gammacoronavirus. IBV is now called Avian Coronavirus, a species in the genus 
Gammacoronavirus (IVCT website, nd). 
 
Morphology 
The morphology of the IBV virion is round to pleomorphic. The envelope is 
approximately 120 nm in diameter and carries club-shaped projections called 
spikes (Cavanagh, 2008). The spikes are relatively large membrane bound 
glycoproteins with a mean size of 20 nm (Cavanagh, 2007). An electron 
micrograph photo of IBV is shown in Figure 1.  
 
Figure 1. Electron micrograph of Infectious Bronchitis virus particles. 
(Photo: Siamak Zohari, SVA) 
 
Gene function and organization  
The IBV genome consists of a single- stranded positive sense RNA and contains 
about 27 600 nucleotides representing both structural and non-structural genes 
(Cavanagh, 2007).  
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The Spike (S) represents one of three major structural proteins (Cavanagh 2007). 
In IBV, along with some other corona viruses, the spikes consist of two subunits 
called S1 and S2 (Cavanagh, 2007). The part of the spike with the appearance of a 
bulb is mostly represented by the S1-unit while the S2- unit is the part anchored to 
the virion membrane. The function of the S-protein is attachment of the virus to 
the receptor at the host cell (S1) and induction of fusion of the membranes of the 
cell and the virion in order for the viral genome to be released into the cytoplasm 
(S2) (Cavanagh, 2007). S1 and S2 consist of approximately 500 and 600 amino 
acids, respectively. The S2 subunit is much more conserved among serotypes than 
the S1 (Cavanagh, 2008).  
The other major structural proteins are the membrane (M) glycoprotein and the 
internal nucleoprotein (N), the latter being closely wrapped around the genome to 
form the ribonucleoprotein. A smaller membrane protein (E), not present to the 
same extent as the others, is associated with the envelope (Cavanagh, 2008). Both 
the M-protein and the E-protein is needed for the formation of the virus particle. 
The E-protein consists of less than half of the number of amino acids as the M-
protein, 100 and 230 amino acids respectively (Cavanagh, 2007).   
Apart from the structural proteins, non-structural proteins needed for RNA 
replication and transcription, and small non-structural proteins, most of these with 
unknown function, are encoded in the coronavirus genome (Cavanagh, 2007). 
IBV carries 15 non-structural proteins for replication and transcription and these 
are encoded in gene 1, or ORF1. The number and the location of the small non-
structural proteins vary between coronaviruses (Cavanagh, 2007). The gene 
organization of IBV is shown below (Figure 2). The small non-structural proteins 
genes of IBV are named 3 and 5 and they encode three and two proteins, 
respectively. 3c is the small membrane E-protein (Cavanagh, 2007).  
 
5’ UTR Gene 1 S 3a 3b 3c (E) M 5a 5b N 3’UTR 
 
Figure 2. The genome organization for IBV (modified from Cavanagh, 2007). The sizes of 
the boxes in the figure do  not correlate to the sizes of the genes.   
The replication of IBV occurs in the cytoplasm. The transcription process is 
discontinuous and results in five messenger RNAs. The virions are formed 
through a budding process in the endoplasmic reticulum and are transported to the 
surface in smooth vesicles. The mechanism behind the final release of the virions 
from the cells is still unknown (Cavanagh, 2008). 
 
Classification 
IBV exist in numerous serotypes and genotypes and new variants continue to 
emerge due to mutations as well as recombination (Jones, 2010). The cross 
protection between different serotypes is poor (Cavanagh, 2008). Both genotype 
and serotype classification is generally based on the S1-subunit of the S-protein 
(Cavanagh, 2008). S1 is the major inducer of virus neutralization antibodies and 
traditionally, cross-neutralization tests have been used for serotype classification 
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(Cavanagh, 2008; Jones, 2010). Genotypes are defined via Reverse Transcriptase 
Polymerase Chain Reaction, usually targeting the S-gene, followed by nucleotide 
sequencing or restriction endonuclease analysis (Cavanagh, 2008). 
A change of only 2-3 % of the nucleotide sequence in the S1-gene, representing 
some 10-15 amino acids, may alter the serotype of the strain (Cavanagh, 1997). 
Some regions of the S1-gene are of greater importance than others when it comes 
to epitopes inducing neutralizing antibodies. The location of these areas is mainly 
in the first and the third quarters of the S1-gene (De Wit, 2000).  
Mean nucleotide difference of the S1-unit is approximately 20-25 % between 
serotypes. Usually the correlation between genotype and serotype is good. 
However, there are strains with greater nucleotide difference that still have been 
grouped in the same serotype using virus neutralization tests. Exceptions to this 
are also available where, although similar in nucleotide sequence of the S1-unit, 
virus neutralization tests defined the strains in different serotypes (Cavanagh, 
2008).  
 
Strain classification in IBV Diagnosis 
Strain classification during IBV diagnosis is very important (Cavanagh, 2008). 
Classification can be based on biological function of the virus using functional 
tests or on the viral genome using non-functional test (De Wit, 2000).  
Functional tests group viral strains in immunotypes or protectotypes (strains that 
induce protection against each other), in serotypes (strains that induce serotype-
specific neutralization antibodies) or epitope-types (strains that contain specific 
epitopes) (De Wit, 2000). Functional tests are useful for the selection of vaccine 
programs since they provide information about the antigenicity of the strain (De 
Wit, 2000).  
Non-functional test groups the strains into genotypes (De Wit, 2000). Methods 
used are genome sequencing, detection of part of the genome that is specific for a 
genotype via RT-PCR or determination of specific enzyme cleavage sites. When 
sequencing is used, part of the S-gene or the N-gene is most commonly analyzed. 
In genotype-specific RT-PCR genotype specific primers are used in combination 
with a universal primer resulting in amplicons of different sizes (De Wit, 2000). 
Cleavage sites are identified via restriction enzymes that cut the PCR product at 
specific cleavage sites, resulting into fragments that produce different 
electrophoresis patterns. These patterns can then be compared to patterns of 
known serotypes (OIE Terrestrial Manual, 2008; De Wit, 2000).  
Non-functional tests are useful in epidemiological studies. Although these 
methods do not provide information neither about the biological function nor the 
antigenicity of the virus (De Wit, 2000), genotyping is increasingly replacing 
traditional serotyping with VN and HI for identification of field strains (OIE 
Terrestrial Manual, 2008). Nucleotide sequencing of important fragments of the 
S1-gene are the most common method used (OIE Terrestrial Manual, 2008). 
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Pathogenicity 
IBV is an epitheliotropic virus that replicates mainly in the epithelium in the 
respiratory tract causing characteristic lesions in the trachea, the primary site of 
replication for all IBV pathotypes. IBV can also replicate in epithelium in other 
tissues such as kidney, intestinal tract and gonads of both males and females 
(Cavanagh, 2008). Furthermore, IBV can replicate in lymphoid organs such as the 
Harderian gland in the eye socket and the bursa of Fabricius (Dhinakar & Jones, 
1997).  
In chicken of very young age, the development of air-sacculitis due to secondary 
bacterial infection or the development of kidney disease will increase the severity 
of the disease (Cavanagh, 2008). Different strains differ in virulence and hence in 
clinical features. Primary nephropathogenic strains exist, some of them causing 
mortality of up to 25 % (Cavanagh, 2008). However, many strains can cause 
nephritis to some extent (Cavanagh, 2007).  
Replication in the enteric tract result in excretion of the virus in the faeces but 
clinical disease is considered rare but not impossible (Villarreal, 2007a; 
Cavanagh, 2007). IBV may also be associated with lesions in the testis and 
infertility in roosters (Villarreal, 2007b). Furthermore, there are strains of IBV 
that induces myopathy in the pectoral muscles in broilers (Gough et al, 1992) and 
others that cause lesions in the proventriculis (Cavanagh, 2008). 
The determinants of pathogenicity of IBV are poorly known (Cavanagh, 2007). In 
other coronaviruses the S-protein has been demonstrated to affect the tissue 
tropism pattern (Kuo et al, 2000). In vitro studies for IBV have shown that the S-
protein affect the host cell range (Casais et al, 2003). The function of the small 
non-structural proteins have been discussed both when it comes to possible 
involvement in pathogenicity and in immune response. However, further research 
is required in this area (Cavanagh, 2007). 
 
Transmission and incubation period 
The virus is spread within a flock through breathing air, direct contact and 
contaminated faeces (Engström et al, 2010). All animals in a naive herd will be 
quickly infected if the virus is introduced. The period of incubation is 18-36 h. 
(Cavanagh, 2008; Engström et al, 2010). Spreading between flocks can occur 
through contaminated objects, equipment and people (Engström et al, 2010). The 
frequency of air-borne spread between flocks is unknown (Cavanagh, 2008).  
Extended and intermittent shedding of virus occurs both due to persistent 
infection and re-excretion. Persistence of IBV infection may be seen in non-
respiratory tissue such as the kidney and intermittent shedding of virus can occur 
via nasal secretions and faeces (Cavanagh, 2008; Dhinakar & Jones, 2007). Re-
excretion has been seen in hens at time of start of lay, if they had been infected as 
younger chickens. The re-excretion occurred although they had recovered from 
respiratory signs and they had had a period of time when viral samples were 
negative (Jones et al, 1987). Vaccination can also contribute to intermittent 
excretion since vaccine virus may persist in various internal organs for months 
(Cavanagh, 2008). 
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Hosts 
IBV was long considered to be limited to infect chicken (Gallus gallus) but results 
from recent research indicate that the host range is much wider (Cavanagh, 2008). 
The emergence of the Severe Acute Respiratory Syndrome, SARS, in 2003 
largely increased the interest of Corona Virus research which resulted in the 
identification of new coronaviruses both in humans and animals (Muradrasoli et 
al, 2010). Avian coronaviruses, some with great identity with IBV, have for 
example been isolated in pheasants, peafowl, teal, partridge and guinea fowl 
although they did not necessarily cause disease (Cavanagh, 2008). However, as 
mentioned previously, current research in Brazil indicates that quails may carry 
and develop disease from IBV. Symptoms with impact on egg production and 
quality, similar to those seen in layers, have been observed (Brandão, 2010). 
Furthermore, turkey and pheasant coronaviruses have shown to be genetically 
related to IBV although they are considered to be distinct species from IBV 
(Cavanagh, 2008; Muradrasoli et al, 2010). During a study of wild birds in the 
Bering area, diverse coronaviruses were found in 18 different avian species. The 
authors suggested that avian coronaviruses may be a genetic reservoir for future 
emerging pathogenic coronaviruses and the need for more studies within this area 
in order to better understand the ecology and the virus -host-interaction was 
illuminated (Muradrasoli et al, 2010).  
 
Clinical signs 
The most severe symptoms are seen in young chickens and include several 
respiratory symptoms such as coughing, sneezing, gasping, tracheal rales and 
nasal discharge (Cavanagh, 2008). Reduced general condition as well as 
depression and huddling are also part of the clinical features. Reduction in food 
consumption and in weight gain is common. The mortality in chicken less than 6 
weeks of age can reach 25 %, the major cause being secondary bacterial 
infections. Infection in newly-hatched chickens, one day of age, can result in 
permanent damage to the oviduct (Cavanagh, 2008).  
In chickens older than 6 weeks and in adult birds the disease can pass unnoticed 
or with mild respiratory signs. Mortality is unusual (Cavanagh, 2008) unless 
complications with secondary bacterial infections occur (Engström et al, 2010). 
However, since the pathogenicity between strains of IBV varies, some strains 
have shown to induce severe disease also in older chickens (Gough et al, 1992).  
Reduced egg production and impaired quality and sustainability of the eggs are 
seen in IBV infected layers. Reduced hatchability, soft-shell, misshapen and 
rough-shelled eggs are some of the features. Respiratory signs may or may not be 
present. The egg production in herds that has undergone infection may be 
permanently reduced (Cavanagh, 2008). Both the time of lay (Eck & Van, 1983) 
and the virus strain (Cook et al, 1986b) has shown to be factors that influence on 
the severity of the production drop.  
Nephropathogenic strains can induce symptoms of uremia in broilers, usually 
after a phase of respiratory signs and a recovering period from these signs 
(Cavanagh, 2008). 
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Mortality and morbidity  
The morbidity within a flock is high and often reaches 100 % (Cavanagh, 2008). 
Mortality varies due to several factors such as virulence of the infecting serotype, 
age, status of immunity, and stresses like cold or secondary bacterial infections. In 
nephropathogenic strains sex, breed and nutrition are further factors that will 
influence on the severity of the kidney disease (Cavanagh, 2008)  
 
Gross lesions and histopathology 
IBV causes an exudative inflammation primarily in the upper respiratory tract i.e. 
trachea, nasal passages and sinuses. The tracheal mucosa is edematous with loss 
of cilia and a decrease in ciliar activity. Impact on air sacs and lungs may or may 
not be present (Cavanagh, 2008; Engström et al 2010).  
Degeneration and loss of cilia is seen in the epithelial and glandular cells of the 
oviduct in adult hen (Cavanagh, 2008; Villarreal, 2007b). Lesions in the 
reproductive tract of one-day-old chicks are mostly located in the middle third of 
the oviduct (Cavanagh, 2008).  
Lesions in the kidneys caused by nephropathogenic strains include swollen and 
pale kidneys with distended tubules and ureters (Cavanagh, 2008). 
Infection in newly-hatched chickens, one day of age, can result in permanent 
damage to the oviduct. Re-excretion of virus has also been shown experimentally 
at time of lay, i.e. around 19 weeks of age, possibly as a result of the stress 
induced by the start of this process (Jones et al, 1987; Cavanagh 2007; Cavanagh, 
2008). 
 
Immunity 
Both antibody and cell mediated immune responses seem to be involved in the 
protection against IBV (Cavanagh, 2008; Pei et al, 2001). Several studies have 
been performed in order to evaluate the role of the B-cells (Dhinakar & Jones, 
1997). A number of adverse effects were seen followed B-cell-depletion such as 
more severe symptoms, prolonged disease duration and more severe lesion in 
tissues such as the kidney (Dhinakar & Jones, 1997). However, further 
mechanisms are also involved as shown in other studies where chickens resisted 
IBV challenge, despite lack of B-cells (Cavanagh, 2008). A variety of evidence 
for cell-mediated immune responses has been reported for example activity of 
natural killer cells and cytotoxic lymphocytes, and infiltration of cytotoxic T-cells 
(CTL) in respiratory and kidney tissues (Cavanagh, 2008). A good correlation has 
been shown between the peak in CTL present 10 days post-infection and the 
clearance of virus from lungs and kidneys (Cavanagh, 2008). 
The S1-subunit plays an important role of the induction of VN and HI antibodies 
and the induction of protective immunity (Ignjatovic, 1994; Cavanagh, 2008). The 
latter was shown in a study where a recombinant chimera of the non-pathogenic 
IBV Beaudette strain and the S-protein gene from a pathogenic strain M41 was 
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created. The recombinant chimera called Beau-R-M41-(S) induced a considerable 
higher level of protection towards challenge with a M41 strain that did the 
original Beaudette although the recombinant virus was non-pathogenic itself 
(Hodgson et al, 2004).  
Local antibody is considered very important (Dhinakar & Jones, 1997) and is 
believed to be involved in the protection of the respiratory tract (Cavanagh, 2007). 
The Harderian gland may also contribute to local immunity (Cavanagh, 2008) 
since it stores plasma cells and is the source of immunoglobulins in the lachrymal 
fluid (Dhinakar & Jones, 1997). Furthermore, local antibodies have been detected 
in the oviducts of hen (Dhinakar & Jones, 1997). 
Post infection, some immunity is developed towards the specific virus strain that 
caused the infection but the immunity to other strains varies (Cavanagh, 2008). 
The virus titer recovered after a challenge is much lower if the birds had been 
vaccinated with a homologous strain prior to the infection (Cook et al, 1986a). 
Although humoral response to IBV is good, there is no clear correlation between 
the antibody titer in sera and the resistance to infection (Dhinakar & Jones, 1997). 
 
Maternal antibodies 
Maternal derived antibodies (MDA) decrease the efficiency of the immune 
response in chicken vaccinated at one day of age if the vaccine is the same that 
had been given to the mother. However, MDA may provide protection against 
IBV challenge in one day old chickens (Cavanagh, 2008).  
 
Control of immunity 
Evaluation of protective immunity after immunization or challenge can be 
addressed in different ways (Cavanagh, 2008). Failure of isolation of IBV from 
trachea a few days post-challenge has been used a single evidence for respiratory 
protection. In order to evaluate the range of protection, a score resulting from the 
assessment of a number of criteria such as absence of tracheal lesions, presence of 
tracheal ciliar activity, failure of IBV recover in kidneys and ovaries and absence 
of clinical signs of IB, can be used (Cavanagh, 2008). Evidence of IB protection 
in strains where respiratory signs are not the major issue, is based on the ability of 
the immune system to suppress the lesions and clinical signs produced by the 
certain type of virus strain i.e. protection against mortality of kidney disease in 
nephropathogenic strains and protection against egg production drop in layers 
(Klieve & Cumming, 1988; Box et al, 1988).  
ELISA targeting the immunoglobulin M (IgM) may be used as an indicator of the 
efficacy of IBV vaccination at around 10 days post vaccination since IgM are 
short-lived and usually only detectable from three- five days until two weeks post-
infection /vaccination (De Wit,2009b).  
 
Diagnosis 
In addition to clinical history and lesions, diagnosis of IB is based on different 
methods for detection of the virus (i.e. antigen, virus isolation or viral RNA) or 
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detection of an antibody response (i.e. seroconversion or an, at minimum four fold 
rise, in IBV antibody titers) (Cavanagh, 2008; De Wit, 2000). As mentioned in the 
chapter of strain classification, identification of serotype or genotype should be 
included in diagnosis of IBV due to the great number of existing types (Cavanagh, 
2008).   
Regarding ongoing or recent disease outbreaks, the exclusion of other possible 
causes should be made since IBV can be persistent and because long-term 
recovery has been reported (Chong & Apostolov, 1982; Alexander and Gough 
1977). 
 
Methods for viral detection  
Collection of samples 
Trachea is the sample site of choice for birds with symptoms of respiratory 
disease, especially when sampling is performed within the first week of infection. 
If more than one week has passed, cloacal swabs or caecal swabs are preferred 
since the virus spread to non-respiratory organs after the initial replication in the 
respiratory tract (Cavanagh, 2008; De Wit 2000). Lungs, kidneys and oviduct may 
also be sampled, depending on the history and the clinical features of disease 
(Cavanagh, 2008).  
 
Virus isolation and detection of IBV antigen 
Virus isolation is commonly performed via inoculation of the sample in 
embryonated Specific Pathogen Free (SPF) eggs or chicken tracheal organ 
cultures (TOC). Even if typical IBV induced changes can be seen such as embryo 
dwarfing and curling (figure 3), feather dystrophy and mortality, and ciliosthasis 
in TOC, fluid must be collected and submitted to a further method for 
confirmation of the diagnosis after 2- 3 days of inoculation (Cavanagh, 2008). 
Methods used include serological analysis like VN, HI and ELISA, and 
immunohistochemistry, nucleatic acid analysis and electron microscopy 
(Cavanagh, 2008).  
 
Figure 3. Embryo dwarfing caused by IBV. (Photo: Siamak Zohari, SVA) 
In addition to virus isolation, direct detection of IBV antigen can be done from 
tissue material using antibody-based methods such as immunofluorescence (IFA), 
Immunoperoxidase assay (IPA) and Agar-gel Precipitation test (AGPT) (De Wit, 
2000). All methods for antigen detection use either antisera containing antibodies 
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against different parts of the virus or monoclonal antibodies (Mabs) against one or 
more epitopes (De Wit, 2000). IFA and IPA are more commonly used than AGPT 
and antigen ELISA because of the general image of low sensitivity of the AGPT 
and the relatively high amount of virus needed for the antigen-ELISA (De Wit, 
2000).  
 
Detection of IBV genome 
The use of Polymerase Chain Reaction (PCR) for IBV genome detection is 
increasing (De Wit, 2000). In identification of field strains, this method has 
replaced the traditionally used HI and VN tests because of its ability to identify a 
wide range of different genotypes (Cavanagh, 2008). As mentioned above, initial 
multiplication of the virus may be performed in vitro using embryonated SPF eggs 
or TOC in order to increase the viral titer and hence, the sensitivity of the analysis 
(De Wit, 2000). Before submitting the samples to RT-PCR, genomic RNA is 
extracted from the samples and cDNA is created using the enzyme reverse 
transcriptase. A Nested PCR step adds more sensitivity to the test since a second 
amplification step is performed using the first round PCR product as template 
(Cavanagh, 2008; De Wit 2000).  
Factors that may influence the outcome of the RT-PCR is  the possible presence 
of non-specific inhibitors of the PCR enzyme in the samples (Kwon et al., 1993) 
and the amount of cations such as Mg2+ and Mn2+ (Jackwood et al., 1997). 
Nonspecific inhibitors can be reduced by RNA purification prior to the RT-PCR 
(Kwon et al., 1993). 
After the RT-PCR, the PCR product is further analyzed using nucleotide 
sequencing, restriction enzyme length polymorphism (RFLP) or S1 genotype 
specific RT-PCR (Cavanagh, 2008). In RFLP different genotypes can be 
identified due to unique electrophoresis banding patterns as a result of the 
digestion of the SI RT-PCR product by restriction enzymes (Cavanagh, 2008). In 
S1 genotype specific RT-PCR a combination of a universal primer and genotype 
specific primers are used in order to identify different genotypes (Keeler et al., 
1998). Both RFLP and S1 genotype specific RT-PCR is limited to identification 
of already known genotypes (Cavanagh, 2008). Nucleotide sequencing, however, 
has the advantage to be able to identify new, previously unknown, genotypes. 
Sequencing of the S1 gene is the most useful method for IBV differentiation and 
also the most widely used. Further advantage with sequencing includes the 
possibility of phylogenetic studies where the relatedness of the strains is outlined 
(Cavanagh, 2008) 
 
Methods for antibody detection 
For serology analysis, paired samples should be obtained at onset of disease and 
two to four weeks after. Methods available are AGPT, ELISA, Hemagluttinin 
inhibition (HI) test and Virus Neutralization test (VNT) (De Wit, 2000). VN, HI 
and ELISA are usually used for routine diagnosis (De Wit, 2000) where ELISA 
and HI-test are considered to be most useful (OIE Terrestrial Manual, 2008).  
 13 
ELISA is a group-specific test and detection of antibodies can be made one week 
post infection (De Wit, 2000). Several commercial kits for ELISA are available 
(Cavanagh, 2008). Although HI and VN test are considered to be type specific, 
cross reactions exist, especially in HI test (Cavanagh, 2008). In young, 
unvaccinated birds, VNT is golden standard for determination of serotype (De 
Wit, 2000). However, this is seldom the case in the field where most chicken have 
been vaccinated against, and possibly infected with, IBV resulting in a sera 
containing a broad antibody response (Cavanagh, 2008). AGPT is not 
recommended for antibody detection because of the relatively low sensitivity and 
because of the short lives of the precipitating antibodies (Cavanagh, 2008; De Wit 
et al. 1997). 
Several factors affect the detection of antibodies. The humoral response may be 
decreased or delayed due to factors such as young age, presence of maternal 
derived antibodies (MDA) and recent vaccination or infection with homologous 
serotypes. In older birds that have received several vaccinations, or been 
previously infected, cross-reactions between antibodies of different serotypes 
results in the use of serology being limited to monitor prevalence (De Wit, 2000).  
  
Differential diagnosis 
For the clinical acute respiratory disease differential diagnosis include infectious 
laryngotracheitis (genus Iltovirus within family Herpesviridae) (Guy & Garcia, 
2008), low pathogenic avian influenza, infectious coryza (Avibacterium 
paragallinarum) (Blackall, 2008) and lentogenic pneumotropic strains of 
Newcastle disease (genus Avulavirus within family Paramyxoviridae) (Alexander 
& Senne, 2008) (Cavanagh, 2008). The production and quality drop of eggs may 
resemble the egg drop syndrome caused by adenovirus (Cavanagh, 2008). 
 
Treatment 
Treatment for IBV consists of supporting procedures and minimization of stresses 
such as cold stress and overcrowded animal facilities (Cavanagh, 2008). 
Antibiotics may be used if complications such as air sacculitis due to secondary 
bacterial infections are present. In cases of nephritis, electrolyte replacers may be 
supplied in the drinking water (Cavanagh, 2008). 
 
Biosecurity 
Biosecurity includes the management procedures executed in order to prevent the 
entrance of any infective agents (i.e. virus, bacteria, protozoa, and parasites), 
insects, rodents and wild birds to the farm which could jeopardize the health status 
of the flock (Bermudez & Stewart-Brown, 2008). The term includes a wide 
variety of factors, among them design of animal facilities, location of the farm 
related to other farms, location of the buildings within the farm to each other, 
routines for procedures, staff, visitors, transporters etcetera. Other factors such as 
good quality of feed and water and optimal environment for the birds are also 
included. Proper cleaning and disinfection between batches and an “all-in-all-out” 
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routine are desirable when it comes to biosecurity but may not always be possible 
for example in layer farms where flocks of different ages are present (Bermudez 
& Stewart-Brown, 2008). 
Because of the nature of IBV with rapid transmission, high morbidity and major 
production loss resulting in financial loss, management measures are often not 
enough to control disease. Immunization is an important tool and both live and 
inactivated virus vaccines are being used (Cavanagh, 2008). However, the number 
of different strains present and the tendency of the virus of constant emerge makes 
the control hard (Cavanagh, 2008).  
  
Vaccination 
Vaccines of Massachusetts serotype such as H120 and M41 are commonly used 
all over the world (OIE Terrestrial Manual, 2008). In some countries, like Brazil, 
these represent the only serotypes allowed to be used as live vaccines although 
other serotypes are present in the field (Villarreal et al, 2010; Brandão et al, 
2009).  
Live vaccines are produced from field strains via passage in embryonated egg 
leading to attenuation (Cavanagh, 2007). Live vaccines are more efficient in 
inducing a local immunity in the respiratory tract (OIE Terrestrial Manual, 2008) 
and are considered to provide a greater width of protection (Cook et al, 1999). 
The disadvantage with live vaccines is the risk of regain of pathogenicity and 
back-passage within the flock. In order to decrease this risk, simultaneous 
vaccination of all birds is recommended, especially in farms where birds of 
different age are present (OIE Terrestrial Manual, 2008).  
 
Vaccination routines 
Vaccination of broilers with live vaccines is usually performed in the hatchery at 
one day of age. In areas with high frequencies of IBV re-vaccination may be used, 
sometimes with another serotype than that of the first vaccination (Cavanagh, 
2007). Administration routes of live vaccines include aerosols, application in 
drinking water and intraocular eye drops (OIE Terrestrial Manual, 2008).  
Mass vaccination administration is commonly used but the accuracy may be 
compromised when it comes to application technique and dosage. Further factors 
that may affect the level of protection yielded from vaccination include 
immunosuppression and time between vaccinations and challenge (De Wit, 
2009a). 
Layers commonly receive a series of live and inactivated vaccines, starting at the 
age of two or three weeks (Cavanagh, 2007). More than one serotype may be 
given in order to increase the width of the protection (Cook et al, 1999). Before 
start of lay, killed vaccines are given (Cavanagh, 2007). Inactivated vaccines must 
be primed with a live vaccine in order to be efficient (OIE Terrestrial Manual, 
2008). Administration routes for inactivated vaccines include intramuscular or 
subcutaneous injections (OIE Terrestrial Manual, 2008).  
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The use of two heterologous vaccines has shown to significantly increase the 
protection against variants although the mechanism behind this is still poorly 
understood (Jones, 2010; Cook et al, 1999; Ganapathy et al, 2009). In addition, 
layers that received an inactivated IBV M41 vaccine after initial vaccination with 
two live vaccines got a better protection both against ciliosthasis and drop in egg 
production (De Wit, 2009a).  
In order to meet the challenge of the antigenic diversity of IBV, molecular 
technology may be an increasingly important tool in vaccine development in the 
future. One example of a technique within this area is recombination of different 
IBVs regarding the S-gene called “spike swapping” (Jones 2010; Britton, 2009).  
Another field of vaccine research is that of in-ovo vaccination (Jones 2010) where 
already some promising results has been shown (Khalesi, 2009).  
 
METHOD AND MATERIALS 
Collection of samples 
Farms and flocks 
Collection of samples from layer hen was made during one week in September 
2011 in Bastos, a small town in São Paulo State in the southwest part of Brazil. 
Bastos represents one of the main regions for layers in Brazil and the area houses 
15 million chickens and 4 million quails.  
Organ and blood samples were collected from four farms that had reported 
problems with respiratory disease. Three of the farms (here referred to as A, B and 
D) had previously participated in a study regarding quails as reservoirs for IBV. 
Blood samples were also collected from a fifth farm (referred to as E) where no 
organs samples were taken. The farms were chosen on the basis of willingness to 
participate and because of the already-established contact due to participation in 
previous studies. The total number of birds at the participating farms is presented 
in table 1. At three of the farms, these numbers were unknown.  
Table 1. Number of birds present at the participating farms distributed on chicken and 
quails 
Farm Total number of 
birds 
Chicken Quails 
A 136 000 86 000 50 000 
B 1 800 000 1 300 000 500 000 
C U U 0 
D U U U 
E U U 0 
U = unknown 
A total of 66 layers from 13 flocks (3-4 flocks per farm) were included in the 
study. The flocks were of different age and represented both layers in production 
and immature hen. Both birds with and without respiratory symptoms were 
chosen for collection. The birds were selected by local veterinarians and there was 
little possibility of influencing the selection of individuals. A thorough clinical 
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examination was not performed due to time constraints. Registration of presence 
or absence of clinical symptoms was based on history given by the accompanying 
person representing the farm.  
 
Organ samples 
Organs samples were collected postmortem as pools of 5-6 birds. The birds were 
euthanized via dislocation of the neck. The different pools consisted of trachea, 
lungs, kidneys, reproductive tract (i.e. ovaries and oviduct) and enteric content, 
predominantly from the caecum. At collection, gross pathological lesions were 
registered but no thorough necropsy was performed due to time constraints. The 
organ samples were kept cold during transport to the laboratory at the University 
of São Paulo and were then stored in -20 º C.  
 
Blood samples 
Blood samples were collected from 5-20 birds per flock resulting in a total 
number of 182 samples. Five milliliters of blood per bird was collected from the 
vein v. cutanea ulnaris on the wing. Blood sampling was performed in the same 
flocks, but not from the same individuals, from which the organ samples were 
taken. From the fifth farm (E), where no organ samples were retrieved, five flocks 
were sampled. The birds as well as the number of birds were selected by local 
veterinarians and there was little possibility of influencing this selection. The 
blood was kept in outdoor temperature at around 30º for approximately 3 hours 
and was then kept in room temperature for another 20 hours in order for the sera 
to separate. After 24 hours the sera was transferred to new tubes and were kept 
refrigerated until, and during, transport to the laboratory at the University of São 
Paulo. At the laboratory the samples were stored in -20 º C. 23 samples was 
discarded due to hemolysis or insufficient amount of sera required for the 
analysis, resulting in a total number of 159 useable samples.  
 
 
Additional information 
In addition to sample collection, information regarding age and breed were 
retrieved. Presence or absence of clinical symptoms was registered. Biosecurity 
was studied through own observations and registration of the routines for visitors 
at the farms. Vaccination routines for quails against IBV were registered.  
 
Laboratory methods 
Background on laboratory methods used 
Polymerase chain reaction 
Polymerase chain reaction, PCR, is a method for amplification of a specific 
fragment of DNA using a series of temperature changes initiating the different 
steps in the procedure. Several components are required for the reaction: 
termostabile DNA-polymerase to catalyze the synthesis of DNA, a pair of 
synthetic oligonucleotides to prime DNA synthesis, equimolar amounts of the 
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deoxynucleoside triphosphates (dNTPs) dATP, dTTP, dCTP and dGTP, buffer 
solution to maintain pH, divalent cations such as magnesium (Mg2+ ) or 
manganese (Mn) ions, and a monovalent cation, such as potassium chloride 
(KCL). For routine PCR Taq-polymerase is the most commonly used termostabile 
DNA polymerase. The buffer solution normally constitutes of Tris-Cloride. The 
presence of free divalent cations is crucial for the activity of the enzyme. Since 
both the dNTPs and the primers bind cations, the amount of the latter must be 
greater than the molar concentration of the phosphate groups of the dNTPs and 
the primers. Hence, the optimal concentration of Mg2+ differs between reactions 
and optimization is made empirically. The design of the oligonucleotides is very 
important since they have a prominent influence on the efficiency and the 
specificity of the amplification reaction (Sambrook and Russel, 2001).  
The main processes involved in the PCR reaction is denaturation of the double 
stranded DNA template by heat, annealing of the primers to the target sequence of 
the template and the extension of the primers by termostabile DNA polymerase. 
The steps are repeated in a number of cycles in order for the target sequence to be 
amplified in a satisfactory amount that largely exceeds that of the unwanted 
nonspecific amplification products, which should be barely detectable or, 
preferentially, not detectable at all (Sambrook and Russel, 2001). 
In a Nested PCR, the product of the first round PCR is used as template and the 
oligonucleotide primers are replaced in order to reduce the size of the amplicon. 
Nested PCR increase the sensitivity of the PCR (Cavanagh 2008) and decrease the 
risk of non-specific amplification of DNA (Brandão, Personal Communication 
2011-10-31). 
The result of the PCR is made visible through an agarose gel electrophoresis. The 
PCR product fragments run through the gel with a migration correlated to their 
size and a band pattern will be created. The bands are then compared with a DNA 
ladder, containing DNA fragments of known size, and a positive control. 
Sequencing 
The PCR product can be further analyzed through a number of methods including 
DNA sequencing. DNA sequencing allows positive IBV samples to be 
distinguished into genotypes. The Sanger method of DNA sequencing is widely 
used and is based on Dideoxy-mediated Chain Termination (Sambrook and 
Russel, 2001). The dideoxynucleoside triphosphates (ddNTPs) differ from 
deoxynucleotides in that they lack a 3´-hydroxyl residue and instead carry a 
3´hydrogen residue. This does not affect the ability of the ddNTPs to be 
incorporated into the DNA chain by DNA polymerases, but an extension of the 
strand past the ddNTPs is not possible since the 3´hydroxyl residue is needed for 
the formation of a 5´à 3´phosphodiester bond. Hence, the ddNTPs will work as a 
terminator (Sambrook and Russel, 2001). Since the possibility that the DNA 
polymerase will add a dNTPs to the DNA strand is equal to that of the addition of 
a ddNTP, all possible fragments will be created if a sufficient number of cycles is 
performed.  
The components needed for the DNA sequencing process are DNA template, a 
DNA polymerase like Taq polymerase, primer, buffer solution and equimolar 
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amounts of the four deoxynucleotides (dNTPs) and the four dideoxynucleoside 
triphosphates (ddNTPs). The latter is labeled with a fluorescence marker that is 
color-specific for each base.  The DNA sequence is then analyzed in a sequencing 
machine. The sequencing machine used in this study was an ABI 3500 containing 
capillaries with polymers inside where laser beams register the color which each 
represents one base. 
Genotype Specific Multiplex PCR 
Genotype specific Multiplex PCR is a method for identification of already 
described genotypes. The PCR include the use of several primers specific for  
given genotypes, in combination with a universal primer. Annealing of the 
different primers will yield amplicons of different size and the fragment sizes can 
then be used to recognize the genotypes using an agarose gel electrophoresis 
(Keeler et al, 1998).  
 
Execution at the lab 
Extraction of RNA 
The organ samples were cut in small pieces and mixed with DEPC-treated water 
in a 50/50 suspension. 
The organ suspensions were frozen, thawed and homogenized via vortexing three 
times in order to break the cellular membranes. Liquid nitrogen was used to 
accelerate the freezing process. The organ suspensions were then clarified through 
centrifugation in 4 º C, 5000 g (RCF) for 10 minutes. 250 µl of the supernatants 
were collected and added to new tubes containing 750 µl Trizol (containing 
Guanidine, Phenol pH 4 and pH indicator) for further breakage of cellular 
membranes and denaturation of proteins but preservation of the integrity of the 
RNA. 250 µl of DEPC-treated water and 250 µl of a virus reference strain were 
used as negative and positive controls, respectively. The virus reference strains 
included the Massachusetts vaccine strain MA5 and Ceva Big Vacina and the 
Massachusetts field strain Cobb 3/6p 
 
Following homogenization via vortexing and 5 minutes in room temperature, 200 
µl of Chloroform was added to the tubes in order to separate the solution into an 
aqueous phase and an organic phase. Another session of vortexing was performed 
and after 10 min in room temperature the samples were centrifuged in 4 ºC, 
12 000 g (RCF) for 15 minutes. 500 µl of the supernatant was added to new tubes 
containing 500 µl of Iso-propanol in order to agglutinate RNA by removing the 
water molecules between the RNA-molecules. After careful mixing, 
centrifugation at same temperature, velocity and time as mentioned above was 
performed.   
 
The liquid phase was discarded in a container with one part water and one part 
chloride. The tubes with the remaining pellet were left to air-dry upside down 
before 950 µl of 75 % Ethanol was added to clean of remnant of Iso-propanol. 
The procedure with centrifugation (4 º C, 10 000 g, and 10 min), discarding the 
liquid phase and air-drying (57º C, 10 min) was repeated. Finally, 20 µl of DEPC-
treated water was added and the samples were mixed via a short episode of 
 19 
vortexing followed by a quick spin and was then heated in 57 º C 5 minutes. The 
RNA was then kept in a box with ice until storage at -80º C. 
Reverse Transcription 
3, 5 µl of the RNA yielded from the extraction was denaturized at 94 º C for 5 
minutes, using a termocycler.  A reverse transcription master mix was prepared 
containing random primer, dNTPs, di-thio-threitol (DTT), 5x Strand buffer, 
DEPC-treated water and reverse transcriptase (RT) enzyme. The RT enzyme had 
been prepared from a murine retrovirus named Maloney Murine Leukemic Virus. 
6, 5 µl of the mix was added to the RNA and the reverse transcription was 
performed in the termocycler using the program RT 37. 
 
Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) 3’UTR 
A Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and a Nested 
PCR was performed to screen for IBV. The target sequence of the first round PCR 
was a fragment of 266 bp located in the 3’ untranslated region (UTR). The 
primers used were UTR 41+ and UTR 11-. In the second, nested step the primer 
UTR 11- was replaced with UTR 31 – in order to generate an amplicon of 179bp. 
The process was carried out as described by Cavanagh et al. (2002).  
 A PCR master mix was prepared by the addition of the primers UTR 41 and UTR 
11 and DEPC-treated water to a pre-mix containing Taq-polymerase, MgCl, 
buffer and dNTPs. 2.5 µl of cDNA was added to 22.5 µl of mix. The program 
used in the termocycler was 3 UTR. The specific cycles for 3 UTR, and the 
general function of each step, are presented in Table 2. Step 2-4 were repeated 24 
times. 
Table 2. The cycles for, and the general function of each step, of RT-PCR 3’UTR 
Step number and title Temperature (ºC) Time (min) Function 
1) Denaturation 94  4 Denaturation of 
antibodies bound to the 
Taq-   polymerase i.e. 
enabling function of the 
enzyme            
2 ) Melting 94                 1 Separation of DNA 
strains 
3) Annealing 48                 1,5 Activation and binding 
of reverse and forward 
primer to the DNA 
strain 
4) 
Extension/elongation 
72                 2 Activation of 
polymerase. Extension 
of strands 
5) Final extension 72                 10 Final extension 
6) Hold 4                   forever Hold 
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Nested RT-PCR 3’UTR 
The product amplicon obtained in the first round of PCR was submitted to a 
second nested round of PCR. A master mix was prepared according to the 
procedure described above and the same program was used in the termocycler. 
The primers used were UTR 41+ and UTR 31-.  
 
Electrophoresis 
An agarose gel of a concentration of 1.5 % was prepared from agarose powder 
and 0.5 x TBE buffer solution. A DNA ladder was deposited in the first and the 
last well followed by the deposition of the nested PCR products in the remaining 
wells. The electrophoresis process, where the negative charged DNA runs towards 
the positive pool, was performed at 10 V per centimeter of gel for approximately 
90 minutes. Before the DNA was detected by ultraviolet transillumination using 
the software Gene snap, the gel was stained with ethidium bromide. The size of 
the fragments representing the bands seen on the gel, were estimated via 
comparison with the DNA ladder where each step represented 100 basepares. 
 
RT-PCR and Nested RT-PCR Spike gene 
In order to be able to determine genotype of the IBVs detected by the 3’ UTR RT-
PCR, the positive samples were submitted to partial amplification of the spike 
gene, Spike gene RT-PCR. Genotype identification is made through analysis of 
the DNA sequence of the Spike gene RT-PCR product (also called amplicon). The 
target of the Spike gene RT-PCR was a 390 bp segment between the nucleotides 
705 and 1094 of the S1 coding region, corresponding to the amino acids 234-364 
of the S1 protein. The primes used for the first round PCR was SX 1+ and SX2- 
and for the second, nested step SX3+ and SX4-. The primers used are considered 
universal for most of the known strains of IBV but the region between them varies 
between individual genotypes and genotype identification is therefore possible 
(Worthington et al. 2008). The process was carried out as described by 
Worthington et al (2008).  The program used in the termocycler was named S-
JONES. 
 
DNA purification and sequencing preparations 
The nested PCR product was amplified in order to achieve a total volume of 45 
µl. The amplified products were submitted to an agarose gel electrophoresis at 
100 V for four hours.  The bands were cut out of the gel with a scalpel, using 
ultraviolet light for improved visibility, and were put in DNAse-free 
microcentrifuge tubes.  
The DNA was purified using Illustra GFX PCR DNA and Gel Band purification 
Kit (GE Healthcare) according to the manufacturer’s instructions. The main steps 
included were 1) addition of a capture buffer to the sample consisting of the 
amplified Nested PCR product in order for the proteins to denaturate and the 
agarose gel to be dissolved; 2) separation of the DNA by filtration through a 
membrane to which the DNA was attached 3) removement of salt and other 
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contaminants by a wash and dry step; and 4) addition of an elution buffer in order 
to release the DNA from the membrane. 
 
Sequencing  
The purified Nested PCR product was submitted to the sequencing reaction which 
was executed using Big Dye terminator sequencing kit. Two identical mixes were 
prepared with sequencing buffer and Big Dye, containing dNTPs, ddNTPs, DNA 
polymerase and buffer. A forward primer was added to one of the mixes and a 
reverse primer to the other. The mixes were distributed to two sets of tubes. The 
purified DNA was then added as template to both sets of tubes. The tubes were 
submitted to the sequencing machine ABI 3500. 
 
Genotype Specific multiplex RT-PCR 
In addition to genotype identification through DNA sequencing, another method 
for genotyping, Genotype Specific multiplex RT-PCR, was performed on the 
samples that were positive for  3’UTR Nested PCR. Primers that were used were 
the universal reverse primer IBVNA and the forward primers 793S, D274S and 
H120S, specific for the genotypes 4/91 (also called 793B), D274 and 
Massachusetts, respectively. The target fragments were 153 bp for 4/91-793 
(nucleotide 958-1111), 217 bp for D274 (nucleotide 895-1111) and 295 bp for 
Massachusetts (nucleotide 817-1111). The genotypes included in the PCR were 
chosen based on availability of already designed oligonucleotide primers.  The 
process was carried out as described by Cápua et al (Cápua et al. 1999).  The 
program used in the termocycler was IBV TYPES.  
 
ELISA 
The 159 sera samples were analyzed using commercial Blocking Enzyme Linked 
Immunosorbent Assay (blocking ELISA) kits from Svanova. In addition, 62 of the 
samples were sent to the lab AVIPA (Avicultura Int. E Patol. Animal) in 
Campinas, São Paulo, for analysis using IDEXX kits. The samples were added to 
the Blocking ELISA microtiter plate which was pre-coated with antigen. 
Antibodies from the samples, if present, will then bind the antigen and block their 
binding sites. Monoclonal antibodies conjugated with Horseradish peroxidase 
(HRP) directed to the antigen were then added to the wells and if no antibodies 
were present in the samples, the binding sites on the antigen-coat will be available 
for the monoclonal antibodies. Upon addition of a substrate, a change of color will 
indicate binding of the monoclonal Horseradish peroxidase antibodies.  Hence, no 
change in color indicates absence of antibodies in the samples and a negative 
result. The results were confirmed using a microplate photometer at the optical 
density (OD) of 450 nm. 
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RESULTS 
Laboratory results  
More than half of the samples were positive for IBV according to the 3’UTR 
Nested PCR. The positive samples were submitted to the Spike-gene RT-PCR but 
unfortunately, no results were obtained on this PCR. Because of lack of results on 
the Spike-gene RT-PCR, genotyping using DNA sequencing was not possible. 
Although it would not result in identification of genotypes, the positive samples 
from 3’UTR RT-PCR were submitted to the DNA sequencing reaction but no 
results were obtained in this process either. An additional method for 
identification of genotypes was used, Genotype-specific Multiplex RT-PCR, 
which resulted in the identification of three 4/91 genotypes among the positive 
samples. The rest of the positive samples were identified as not belonging to 
neither Massachusetts, D274 nor 4/91 genotypes. Almost all of the sera were 
positive for anti-IBV antibodies on the blocking ELISA analysis, both according 
to the Svanova kit and the IDEXX kit. The PCR results are summarized in table 3 
and 4.The results are presented in more details below the tables. 
Table 3. Overview of the positive and negative samples, the classification according to 
the Genotype Specific RT-PCR and information regarding farm, flock and breed from 
where the samples were derived 
Flock Farm Breed Trachea Lungs Kidneys Reproductive 
tract 
Enteric 
content 
35 A Hisex + - 4/91 - + 
36 A Hisex + - + - 4/91 
37 A Hisex - - - - + 
38 B Isa 
Brown 
+ + - - + 
39 B Decalb 
brown 
+ - - - + 
40 B Bovan - - - - + 
42 C U + + + + + 
43 C U + + 4/91 - + 
44 C U + + - - + 
45 C U + + - - + 
46 D Hisex - + - - - 
47 D Isa 
Brown 
+ - + + + 
48 D Isa 
Brown 
- + + - - 
Total   9 7 6 2 11 
+ = IBV positive according to 3’ UTR RT-PCR; Negative for 4/91, Mass and D274 genotypes according to Genotype 
specific Multiplex RT-PCR 
4/ 91 = IBV positive according to 3’ UTR RT-PCR; Positive for 4/91 according to Genotype specific Multiplex RT-PCR 
U = unknown 
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Table 4. Overview of the absolute number and the proportion of positive samples, and the 
proportion of positive samples belonging to Non- 4/91, Non-Mass and Non-D274  
“Variant” genotypes  and 4/91 genotype, per organ pools 
 
Organ Pool Positive 
samples per 
organ pool 
Proportion of 
positive 
samples per 
organ pool (%) 
“Variant” % 4/91 % 
Trachea 9 /13 69.2 100% (9/9) - 
Lungs 7 /13 53.8  100% (7/7) - 
Kidney 6 /13 46.2 66.7% (4/6) 33.3% (2/6)  
Reproductive 
tract 
2/ 13 15.4 100% (2/2) - 
Enteric content 11/ 13 84.6 90. 9 % (10/11) 0.09 % (1/11) 
Total 35 / 65 54.4 91.4 % (32/35) 8.6 % (3 /35) 
 
3’ UTR Nested RT-PCR 
All the 13 flocks sampled had a least one organ pool positive for IBV on the 3’ 
UTR RT-PCR. The total frequency of IBV detection was 54.4 % (35/65). The 
percentage of positive samples per organ pool were 69.2 % (9/13), 53.8 % (7/13), 
46.2 % (6/13) and 15.4 % (2/13) of trachea, lungs, kidneys and reproductive tract, 
respectively. For the pools of enteric content, only 2 out of 13 pools were negative 
for IBV, resulting in a percentage of positive samples of 84.6 %. The results of the 
3’UTR RT-PCR for the enteric content pools is presented in figure 4.  
 
Spike-gene Nested RT- PCR 
The samples that were positive for 3’UTR were further analyzed via Nested RT-
PCR targeting the Spike-gene; however, no results were obtained on this PCR. 
For the analysis of the organ pools of trachea, lungs, kidneys and reproductive 
tract even the positive control (vaccine”Ma5”) failed to produce a band. However, 
the ladders were functional indicating that the reason for failure must have been 
prior to the electrophoresis step. For the analysis of the enteric content, one of the 
two positive controls (field strain Cobb 3/6) produced a band but none of the 
samples. 
 
Sequencing, Genome analysis and Phylogenetic analysis  
Due to failure of the Spike-gene RT-PCR, the positive samples for 3’UTR was 
instead submitted to the DNA sequencing process. However, the sequencing 
process was not successful and no sequences were generated. No genomic 
analysis or phylogenetic analyses were therefore possible. 
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Figure 4. Electrophoresis pattern for 3’ UTR Nested PCR of the 13 pools of enteric 
content. 11 out of 13 samples were positive generating a fragment of approximately179 
basepares. 2 of the positive samples (37 and 38) were weak positive and did not generate 
bands when amplified before sequencing. Negative controls (DEPC-treated water) did 
not produce any bands. Bold figures indicate positive samples.  
L = Ladder 
N = negative control 
P = Positive control (P1 = Field strain “Cobb 3/6 p”; P2 = Vaccine “Ceva Big Vacina”) 
 
Genotype Specific Multiplex RT-PCR 
The samples that were positive for the 3’UTR RT-PCR was submitted to the 
Genotype Specific Multiplex RT-PCR. Three of the samples, two kidney pool 
samples and one enteric content pool sample, was identified as genotype 4/91 
(153 bp) because of the generation of fragments of the size of approximately 150 
basepares (bp). No samples produced bands of the size of 217 bp (D274) or 295 
bp (Mass H120). The samples classified as 4/91 represented 8.6 % (3/35) of the 
total positive samples. The remaining samples, 91.4 % (32/35) were classified as 
Non- 4/91, Non-Mass and Non-D274 genotypes, therefore called “Variants”. The 
results of the Genotype Specific RT-PCR for the enteric content pools are 
presented in figure 5.  
 
 
 
 
← Target fragment 3’UTR, 179 bp 
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Figure 5. Electrophoresis pattern for Genotype Specific RT-PCR targeting the 
serotypes/genotypes 4/91 (153 bp), D274 (217 bp) and H120 Mass (295 bp) of the 13 
pools of enteric content. One sample (36) produced a band corresponding to a fragment 
size of approximately 150 basepares indicating the genotype 4/91. The remaining 
samples did not produce any bands and were therefore classified as “Variants”. The two 
positive controls produced bands corresponding to fragments sizes right below 300 
basepares, as expected for Mass genotypes (295 bp).  
L = Ladder 
N = negative control 
P = Positive control 
 
Serum antibody analysis with blocking ELISA  
The vast majority of the sera samples were positive for anti-IBV antibodies (155/ 
159 = 97.5 % Svanova; 60/62 = 96.8 % IDEXX). Only two of the 159 samples 
(one from flock 35 and one from flock 42) were negative according to the results 
from the Svanova kit. Two samples were classified as doubtful (both from flock 
42). The negative sample from flock 35 was also negative according to IDEXX. 
One of the doubtful samples was positive on IDEXX; the other one was not 
analyzed. One sample that was positive for Svanova was negative on IDEXX 
(from flock 36). An overview of the ELISA results is presented in table 5. 
Table 5. Overview of results on ELISA analysis 
Analyzing kit Total number 
of samples 
analyzed 
Number of 
positive 
samples 
(percentage) 
Number of 
negative 
samples 
Number of 
doubtful 
samples 
Svanova 159 155 (97.5 %) 2 2 
IDEXX 62 60 (96. 8%) 2 0 
 
← 4/91, 153 bp                                                                    
← Positive Control Mass, 295 bp 
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The titers obtained from the IDEXX kit analysis and the classification into titer 
groups made by the analyzing laboratory is presented in Appendix 1. No further 
conclusions were drawn from this data due to lack of information regarding age 
and vaccination date. 
Results on Additional information and Biosecurity 
Clinical history, clinical symptoms and gross pathological lesions 
No thorough clinical examination was performed at time of collection of sample 
but obvious clinical signs such as nasal discharge, dyspnea and swollen head as 
well as impaired egg quality were seen in some flocks (Figure 6 and 7). 
Registration of presence or absence of clinical symptoms were based on history 
given by the accompanying person representing the farm but the information 
available varied greatly between the farms. Due to this, in combination with 
language difficulties and time issues, the total information obtained was 
considered insufficient and therefore, no further conclusions were drawn from 
these findings.  The data obtained on the ages of the sampled flocks were also 
considered inadequate and were not presented as results.  
   
   
Figure 6. Chicken with dyspnea, nasal discharge and sunken eyes. (Photo: Clara Atterby)
    
   
Figure 7. Impaired egg quality resulting in a wrinkled shell. (Photo: Clara Atterby) 
 
Gross pathological changes observed during collection of organ samples post 
mortem included pathological changes in the lungs such as pneumonia, cysts in 
the oviducts and pathological changes in the liver such as hepatomegali, 
liverlipidosis and hepatosis.  
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Biosecurity 
Animal facilities 
The animal facilities comprised of two rows of cages in two to three levels under 
a wooden roof with tiles (figure 8 and 9). No walls were present and the 
ventilation was natural. Two- six birds were present per cage. 
  
 
Figure 8. No walls were present at the animal facilities. The construction was made of 
wood. (Photo: Caroline Olofsson) 
 
 
Figure 9. The animal facilities comprised of two rows of cages in two to three levels. 
(Photo: Caroline Olofsson)   
 
General conditions 
The design of the animal facilities was similar on all of the farms. No walls were 
present and no protection against wild birds existed. At several occasions, wild 
birds were seen sitting on the top of the roof and walking around the housed birds. 
Other animals such as dogs and cats were also present and they were seen both 
outside and inside the animal houses. A zone free of vegetation or with less 
vegetation next to the animal facilities was present at some farms and absent at 
others. The distance between animal houses varied from 6-9 meters (figure 10). In 
general, routines for staff included one person being responsible for a limited 
number of animal houses and the work was restricted to these same houses. 
However, some tasks like collection of eggs and delivery of feed was performed 
by one person, then visiting all the animal units. 
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Figure 10. The distance between the animal houses varied between 6-9 meters. (Photo: 
Caroline Olofsson) 
 
Routines for visitors and Vaccination routines for quails 
Farm A. Devices for manual disinfectant of visiting vehicles were available 
(figure 11). No change of clothes or shoes was required for visitors. Quails were 
not vaccinated against IBV. 
 
Figure 11. At Farm A devices for manual disinfectant of vehicles were available. (Photo: 
Caroline Olofsson)  
Farm B. Cleaning of tires was mandatory for transport vehicles. Visitors were not 
allowed to enter the farm if they had been at another farm the same day. No 
change of clothes or shoes was required. Quails were not vaccinated against IBV. 
Farm C. Visiting vehicles had to pass speed bumps where the car and the tires 
were sprayed with disinfectant. Visitors had to register personal information such 
as name and phone number in a log. No change of clothes or shoes was required. 
Quails were not present at the farm.  
Farm D. Visiting vehicles were sprayed with disinfectant when entering the farm. 
Visitors had to shower and change clothes if they had been to another farm the 
same day. Change of shoes was not mandatory. Quails were not vaccinated 
against IBV.  
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Farm E was not included in the investigation on Biosecurity due to lack of 
information. No person representing the farm was present at time of collection of 
blood samples and no information was therefore available.  
 
DISCUSSION 
IBV is one of the most important diseases in poultry when it comes to financial 
losses all over the world. Brazil, one of the major producers of poultry products, 
has significant difficulties regarding the control of the disease. Despite intensive 
use of vaccines, outbreaks of clinical disease occur (Villarreal et al., 2007a). 
Constant surveillance in order to identify new strains circulating within poultry 
populations is crucial (Jones, 2010) and this study was performed as part of this 
ongoing screening for circulating genotypes in Brazil.  
 
IBV 
The frequency of IBV found in the sampled flocks of Bastos was high. The total 
percentage of positive samples was 54.4 % (35/65). All the flocks had a least one 
organ pool that was positive, indicating that IBV was present in all the sampled 
flocks. The vast majority of the fecal samples, 84.6 % (11/13), were positive. 
However, it is important to keep in mind that isolation of viral genome is solely a 
proof of presence of the virus and does not conclude whether or not it was 
actually replicating and causing disease. Nonetheless, with this said, the isolation 
of IBV in the kidney, a target organ for persistent infection, is more indicative of 
viral replication than isolation from fecal content (Brandão, Personal 
communication, 2011-11-03). In this study, almost half of the kidney pools were 
positive for IBV (6/13; 46.2 %) and it is possible that the isolated strains did 
represent pathogenic strains.  
The initial plan to identify the genotypes of the isolated strains via DNA 
sequencing part of the S1-gene did not succeed due to lack of results on the Spike-
gene RT-PCR. Possible reasons for failure of this RT-PCR include low sensitivity 
of the primers, a relatively low success rate of the PCR reaction (50%), and low 
virus titer in the sample (Brandão, Personal communication, 2011-11-03). The 
protocol used for the S-gene RT-PCR was designed by Worthington et al (2008) 
and has been used successfully in Brazil when identifying both the Brazilian 
genotype and the 4/91 genotype (Villarreal et al, 2010). Therefore, it does not 
seem likely that the failure was due to “old” primers in the sense that the field 
strains had emerged to the extent that the primers no longer would fit the strains. 
There are several possible measures that could have been made in order to 
increase the likelihood of success of the S-gene RT-PCR. One includes the 
addition of a bigger amount of sample material to some or all of the steps in the 
process: more RNA to the cDNA, more cDNA to the PCR reaction or more PCR 
product to the electrophoresis (Brandão, Personal communication, 2011-11-03). 
Another include inoculation and multiplication of the virus in embryonated SPF-
eggs or TOCs (tracheal organ cultures) prior to RNA extraction in order to 
increase the viral titer in the initial sample material (De Wit, 2000). Furthermore, 
a second RT-PCR targeting a different region of the S1- gene could have been 
attempted. 
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Because no sequencing analysis could be made on the S-gene, an attempt to 
sequence the positive samples for 3’UTR was made. Sequencing of this region 
would not enable determination of genotype, as is the case of S-gene region, but 
information regarding whether the strain was derived from a vaccine strain or a 
field strain could have been obtained (Brandão, Personal communication, 2011-
10-17). However, as mentioned above in the result section, the sequencing 
reaction failed. The most probable reason for this is insufficient amount of DNA 
submitted to the reaction (Brandão, Personal communication, 2011-11-03).  
The multiplex Genotype Specific PCR was used as an additional method for 
genotyping. The genotypes included were chosen due to primer availability and 
although they did not represent the dominant genotypes in Brazil, Massachusetts 
is not uncommon and the 4/91-793B genotype has been identified in the country. 
No primers have been designed for the Brazilian Variant genotype to be used in a 
multiplex PCR. The reason for this is probably that DNA sequencing is more 
commonly used for genotyping and hence, no genotype-specific primers are 
needed.  
In the present study, several interesting results were obtained from the Genotype –
Specific PCR.  
Three of the 34 positive samples were identified as the 4/91-793 B genotype. This 
genotype was first isolated in Brazil during a screening study in 2007-2008 
(Villarreal et al, 2010) and the finding was considered an indication of the 
emergence of this genotype into the country. The isolation of the genotype in this 
study, although the number of sampled birds was limited, supports the suggestion 
that the frequency of the 4/91 genotype is truly increasing in Brazil.  
A percentage as high as 91.4 % (31/35) of the samples were classified as 
“Variants” (i.e. they did not belong to any of the archetypical genotypes included 
in the Genotype-Specific PCR; Mass, 4/91 or D274). Without DNA sequencing, 
the exact genotype of these samples cannot be determined. However, considering 
the results of larger studies performed in Brazil the past years, the probability that 
they belong to the Brazilian Variant genotype is very high. Since this national 
genotype was first described in 2007 (Villarreal et al, 2007), a clear dominance of 
this genotype have been reported with frequencies as high as 75 % (15/20) 
(Villarreal et al, 2010) and 92 % (65/75) (Sandri et al, 2008). With these facts in 
mind, it is probable that the unspecified genotypes called “Variants” in this study 
did belong to the Brazilian Genotype.  
Furthermore, there were indications of co-circulation of the “Variant” genotype 
and the 4/91 genotype within the same flocks. The positive 4/91 strains were 
isolated from two kidney pools and one enteric content pool. All of the flocks had 
other pools that were positive for IBV, but these were classified as “Variants”. In 
flock 35 with a 4/91 positive kidney pool, the trachea and enteric content pool 
were IBV positive and classified as “Variants”. In the other flock with a positive 
kidney pool, flock 42, both the pools of trachea, lungs and enteric content were 
positive “Variants” and, finally, the flock with the positive 4/91 enteric content 
pool, flock 36, had positive “Variant” trachea and kidney pools. Co-circulation of 
different strains has been reported before in Brazil (Sandri et al, 2008) and this 
phenomenon further underscores the diversity of the circulating strains in the 
country. 
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Finally, none of the samples were classified as Massachusetts. Since 
Massachusetts represents the only serotype allowed to be used in live vaccine in 
Brazil, it can be concluded that none of the isolated strains were derived from 
vaccine strains.  
 
ELISA 
Almost all of the sera samples analyzed were positive for IBV. This is either due 
to antibody response to vaccination or to antibody response to infection. 
Unfortunately, the time of vaccination in relation to the time of sampling was 
unknown and since both intensive immunization and high frequency of disease is 
present in Bastos, no further conclusions could be drawn from these results. 
However, a correlation between antibody titer and number of positive organ pools 
were observed in some flocks.  For example, flock 35 and 42 had low antibody 
titer and several positive organ pools whereas in flock 37 and 40 that had higher 
titers, viral genome could only be detected in the enteric content pool. 
 
Biosecurity 
The results on Biosecurity in Bastos revealed the measurements to be poor: the 
animal density was very high and the distance between animal facilities within the 
farms as well as the distance between different farms were short. The construction 
of the animal houses with no walls present resulted in the possibility for wild birds 
to come into contact with the housed chicken. At several occasions wild birds 
were seen sitting on the roof top or walking around next to the facilities; domestic 
animals such as cats and dogs were also seen inside the animal houses.  
As the farms were layer farms, animal of different ages, hence with different 
immune status, were present, and simultaneous vaccination of all the birds was 
difficult. No coordination of vaccine time and schedules existed between the 
farms. Coordinated programs would have been desirable since the distance 
between them sometimes was short enough for them to be considered the same 
farm from a biosecurity point of view. The occurrence of close distance farms 
have been referred to as ”mega farms” by Bermudez and Steward-Brown (2008). 
The same authors also described the tendency of concentrated poultry areas with 
high animal density to develop into problem areas when it comes to disease 
control. The lack of a synchronized strategy for immunization, treatment and 
prevention of exposure to disease and risk factors was discussed as a deteriorating 
factor (Bermudez & Steward-Brown 2008). 
Three out of four of the visited farms had quails in addition to chickens. None of 
the farms vaccinated their quails against IBV. The facilities for quails were not 
placed in a restricted area separated from the chickens as would be desirable, but 
instead they were most often housed in facilities in the middle of the farm 
surrounded by houses with layers. Since current research indicates that quails may 
carry and develop diseases from IBV, the quails at the farms may serve as a 
reservoir for the virus, further aggravating the difficulties in control of the disease. 
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Regarding routines for staff and management, Bermudez and Steward-Brown 
(2008) illuminate the fact that people like owners, managers and supervisors, that 
frequently visit different poultry farms and farm units, may be the ones that most 
often jeopardize the health status and the disease control within a farm. On most 
of the visited farms, staff was responsible for a limited number of animal houses 
and did not enter the animal houses they were not responsible for. However, only 
one person was responsible for distribution of feed and collection of eggs, 
respectively, and these people therefore visited all the farm units, thus 
representing a possible risk of disease transmission. 
A recommended routine for visitors include the presence of a separate area such 
as a booth, platform or fenced area from where the visitors can inspect the poultry 
and the procedures at the farms (Bermudez and Steward-Brown, 2008). The 
routines for visitors at the farms in Bastos mainly comprised of disinfectant of the 
vehicle. At one of the farms, visitors could not enter if they had been to other 
farms the same day. At another farm, a mandatory shower and change of clothes 
were required if other farms had been visited the same day. However, since no 
change of shoes was required, the net effect of the change of clothes could be 
questioned.  
 
Limitations of the study 
The information retrieved regarding clinical history and clinical symptoms was 
limited and considered insufficient in order to interconnect with the laboratory 
results and to draw conclusions. The limitations were due both to language 
difficulties and time restraint. For example, it would have been interesting to 
know whether or not the flocks with the positive 4/91 had shown any symptoms 
and if so, what symptoms they presented. As mentioned above in the strain 
classification section, methods for isolation of viral genome such as RT-PCR do 
not provide information regarding active infection, viral replication or 
pathogenicity of the strain. Furthermore, it would have been valuable to know the 
date of the last IBV vaccination in relation to time of sample collection; 
predominantly for the interpretation of the ELISA results. Due to the size of the 
study the number of farms and flocks had to be limited in order for analysis of 
retrieved samples to be implementable within the set time frame. 
Conclusions about Biosecurity in other parts of the country can not be made since 
these areas were not visited. However, via personal communication, the situation 
for layers is considered better in other areas of the country and the biosecurity of 
broilers, breeders and especially parent farms are apparently much more rigorous 
(Villarreal, personal communication, 2011- 09-19).  
 
Final conclusions  
The poultry industry in Brazil meets a true challenge regarding the control of 
Infectious Bronchitis with a strikingly high poultry density, a high prevalence of 
IBV, a large divergence between circulating strains with known poor cross 
protection, and inadequate possibilities of protection via immunization. The 
situation is not improved by the properties of the Coronavirus with rapid 
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transmission, high mutation rate and a tendency for recombination which all result 
in the constant emerge of new serotypes and genotypes. The title of a lecture held 
by Brandão at a Workshop on Infectious Bronchitis 2009 summarizes the 
intricacy of the situation in the country:” Avian Infectious Bronchitis Virus in 
Brazil -A highly complex virus meets a highly susceptible host population”.  
Previous studies have concluded that the vaccine failure in Brazil is due to the 
presence of strains divergent from the Massachusetts with poor cross protection 
rather than poor cross protection between field Mass strains and vaccine Mass 
strains (Villarreal et al, 2008; Villarreal et al, 2010). Furthermore, the 
development and emerge of variant genotypes in Brazil has been suggested to be a 
result of the fact that Massachusetts live vaccines are the only ones allowed to be 
used (Sandri et al, 2008). Cavanagh (2008) underlines the importance of 
correlation between the vaccine schedule and the prevalence of serotypes within a 
given region in order to provide the birds with adequate protection. This is 
something that is not met in Brazil under the current circumstances and probably 
serves as one of the biggest obstacle for IBV control. The reason given by the 
Brazilian Ministry of Agriculture for only permitting live vaccines of 
Massachusetts type is the risk of entrance of “new” strains into the country. This 
despite the fact that researchers have presented several studies that have shown 
that strains other than Massachusetts already exist in Brazil (Villarreal 2007a; 
Villarreal 2007b; Sandri et al 2008; Villarreal 2010) and despite the fact that 
vaccination with more than one type of live vaccine has shown to increase the 
level of protection towards IBV (Cook et al, 1999; Ganapathy et al, 2009). 
Altogether, it seems like the poultry industry in Brazil will have a significant 
disadvantage in the fight towards the Infectious Bronchitis Virus as long as the 
vaccination restriction is present.  
Regarding biosecurity, Bastos face a complex situation. An improvement of the 
level of biosecurity would require involvement and engagement of all the farms 
due to the close distance between them. The animal facilities would have to be 
rebuilt in order to prevent contact with wild birds. Considering the number of 
birds, and hence the number of animal houses, this would require large 
investments that may not be feasible for some of the farm owners. Furthermore, 
routines for visitors and staff would have to be reviewed and would require 
determination and conviction of the importance of biosecurity.  
In conclusion, the results of this study with high IBV frequency, a predominance 
of non-Massachusetts genotypes and the finding of the 4/91 genotype were 
consistent with larger studies previously performed in Brazil. Therefore, the 
present results may be considered valuable in the ongoing screening for 
circulating IBV genotypes in the country, a screening that hopefully will end up 
giving Brazil the tools for outlining strategies for optimization of disease control 
in the future.  
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APPENDIX 1.  
Antibody titers obtained from IDEXX kit analysis and Classification into titer 
groups made by the analyzing laboratory 
 
Flock Farm Titer Titer Group 
35 A 172 0 
35 A 929 1 
35 A 1401 2 
35 A 2782 3 
36 A 200 0 
36 A 6439 7 
36 A 8423 8 
37 A 4964 5 
37 A 6961 7 
37 A 11703 9 
37 A 14480 11 
38 B 12330 10 
38 B 15579 11 
38 B 21581 14 
39 B 7791 7 
39 B 9698 8 
39 B 14995 11 
40 B 3510 4 
40 B 4532 5 
40 B 8204 8 
42 C 307 0 
42 C 416 1 
42 C 438 1 
42 C 675 1 
42 C 2291 3 
43 C 4532 5 
43 C 4543 5 
43 C 10316 9 
43 C 10356 9 
43 C 10526 9 
44 C 832 1 
44 C 1015 2 
44 C 1060 2 
44 C 2174 3 
44 C 2983 3 
45 C 10854 9 
45 C 12770 10 
45 C 15673 11 
45 C 17975 12 
45 C 21554 14 
46 D 1750 2 
46 D 6339 7 
46 D 7752 7 
46 D 9620 8 
47 D 8877 8 
47 D 9684 8 
47 D 15088 11 
 2 
47 D 18070 13 
48 D 3655 4 
48 D 4324 5 
48 D 14073 11 
48 D 18372 13 
41 E 7369 7 
41 E 9319 8 
41 E 12528 10 
50 E 539 1 
50 E 696 1 
50 E 1728 2 
51 E 4398 5 
51 E 14343 11 
52 E 9319 8 
52 E 9594 8 
 
 
